DigestRedComo funciona
Red
/
Empresas
Te
No verificado

Teva Pharmaceutical Industries Ltd

Sobre qué escribimos

Anuncios brevesFarmacéuticaFinanzasGestión empresarial/Administración de EmpresasMedicina Salud Bienestar

85 Comunicados de prensa

Ver todos los comunicados de prensa
28/01/2026
Farmacéutica
Gestión empresarial/Administración de Empresas
Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential
Fuente
Teva Pharmaceutical Industries Ltd
Editor
GLOBENEWSWIRE
1.00
0
27/01/2026
Farmacéutica
Medicina Salud Bienestar
Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’
Fuente
Teva Pharmaceutical Industries Ltd
Editor
GLOBENEWSWIRE
1.00
0
14/01/2026
Farmacéutica
Medicina Salud Bienestar
Anuncios breves
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
Fuente
Teva Pharmaceutical Industries Ltd
Editor
GLOBENEWSWIRE
1.00
0
11/01/2026
Farmacéutica
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
Fuente
Teva Pharmaceutical Industries Ltd
Editor
GLOBENEWSWIRE
1.00
0
11/01/2026
Farmacéutica
Medicina Salud Bienestar
Gestión empresarial/Administración de Empresas
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Fuente
Teva Pharmaceutical Industries Ltd
Editor
GLOBENEWSWIRE
1.00
0
05/01/2026
Farmacéutica
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
Fuente
Teva Pharmaceutical Industries Ltd
Editor
GLOBENEWSWIRE
1.00
0
24/12/2025
Farmacéutica
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
Fuente
Teva Pharmaceutical Industries Ltd
Editor
GLOBENEWSWIRE
1.00
0
19/12/2025
Farmacéutica
Medicina Salud Bienestar
Gestión empresarial/Administración de Empresas
Anuncios breves
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
Fuente
Teva Pharmaceutical Industries Ltd
Editor
GLOBENEWSWIRE
1.00
0
12/12/2025
Farmacéutica
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Fuente
Teva Pharmaceutical Industries Ltd
Editor
GLOBENEWSWIRE
1.00
0
12/12/2025
Farmacéutica
Medicina Salud Bienestar
Teva Releases Q4 2025 Aide Memoire
Fuente
Teva Pharmaceutical Industries Ltd
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0